A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 35/36 (2006.01) A61K 35/12 (2006.01) A61K 45/00 (2006.01) A61P 21/00 (2006.01) A61P 25/04 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2503810
A remedy for fibromyalgia containing an extract of a tissue suffering from vaccinia virus inoculation-induced inflammation as the active ingredient, use of the extract of a tissue suffering from vaccinia virus inoculation-induced inflammation as the active ingredient for producing a medicinal composition for treating fibromyalgia, and a method of treating fibromyalgia which comprises administering a medicinal composition containing the extract of a tissue suffering from vaccinia virus inoculation-induced inflammation as the active ingredient to a patient. The remedy containing the extract of a tissue suffering from vaccinia virus inoculation-induced inflammation as the active ingredient is a novel remedy for fibromyalgia no efficacious remedy for which has been known so far. Moreover, it is highly useful as a highly safe and potent drug with scarcely any side effects.
L'invention concerne : un remède contre la fibromyosite contenant, comme principe actif, un extrait d'un tissu souffrant d'une inflammation induite par inoculation du virus de la vaccine ; l'utilisation dudit extrait de tissu souffrant d'une inflammation induite par inoculation du virus de la vaccine comme principe actif pour la production d'une composition médicinale destinée au traitement de la fibromyosite ; et un procédé de traitement de la fibromyosite qui consiste à administrer à un patient une composition médicinale contenant, comme principe actif, l'extrait d'un tissu souffrant d'une inflammation induite par inoculation du virus de la vaccine. Ledit remède, qui contient, comme principe actif, l'extrait d'un tissu souffrant d'une inflammation induite par inoculation du virus de la vaccine est un nouveau remède contre la fibromyosite, maladie pour laquelle aucun remède efficace n'est actuellement connu. En outre, ce remède très sûr et puissant n'a presque pas d'effets secondaires.
Nishioka Kusuki
Gowling Lafleur Henderson Llp
Nippon Zoki Pharmaceutical Co. Ltd.
Nishioka Kusuki
LandOfFree
Therapeutic agent for fibromyalgia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic agent for fibromyalgia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for fibromyalgia will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1936100